Medirom Healthcare [MRM] vs Rollins [ROL] Detailed Stock Comparison
Medirom Healthcare
NASDAQ
Loading...
Rollins
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Medirom Healthcare wins in 6 metrics, Rollins wins in 11 metrics, with 0 ties. Rollins appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Medirom Healthcare | Rollins | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.47 | 57.37 | Medirom Healthcare |
| Price-to-Book Ratio | 0.02 | 19.45 | Medirom Healthcare |
| Debt-to-Equity Ratio | 400.54 | 66.99 | Rollins |
| PEG Ratio | N/A | 7.74 | N/A |
| EV/EBITDA | 12.54 | 36.04 | Medirom Healthcare |
| Profit Margin (TTM) | 1.79% | 13.71% | Rollins |
| Operating Margin (TTM) | 13.30% | 19.95% | Rollins |
| EBITDA Margin (TTM) | 13.30% | 19.95% | Rollins |
| Return on Equity | 22.96% | 36.52% | Rollins |
| Return on Assets (TTM) | 0.04% | 14.37% | Rollins |
| Free Cash Flow (TTM) | $-12.84M | $580.08M | Rollins |
| Dividend Yield | N/A | 0.87% | N/A |
| 1-Year Return | -69.74% | 15.56% | Rollins |
| Price-to-Sales Ratio (TTM) | 0.00 | 7.86 | Medirom Healthcare |
| Enterprise Value | $25.02M | $28.92B | Rollins |
| EV/Revenue Ratio | 0.45 | 8.10 | Medirom Healthcare |
| Gross Profit Margin (TTM) | N/A | 53.79% | N/A |
| Revenue per Share (TTM) | $1,625 | $7 | Medirom Healthcare |
| Earnings per Share (Diluted) | $0.19 | $1.01 | Rollins |
| Beta (Stock Volatility) | 0.88 | 0.69 | Rollins |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Medirom Healthcare vs Rollins Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Medirom Healthcare | 1.67% | -17.81% | 30.43% | 127.85% | 104.55% | 78.22% |
| Rollins | 0.88% | 0.10% | 4.58% | 0.89% | 14.14% | 25.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Medirom Healthcare | -69.74% | -73.66% | -87.71% | -87.71% | -87.71% | -87.71% |
| Rollins | 15.56% | 68.04% | 57.96% | 365.38% | 1,292.79% | 2,119.92% |
Performance & Financial Health Analysis: Medirom Healthcare vs Rollins
| Metric | MRM | ROL |
|---|---|---|
| Market Information | ||
| Market Cap | $14.22M | $28.08B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 13,755,920 | 1,221,540 |
| 90 Day Avg. Volume | 4,601,657 | 1,558,340 |
| Last Close | $1.83 | $58.45 |
| 52 Week Range | $0.34 - $8.39 | $45.34 - $59.10 |
| % from 52W High | -78.19% | -1.10% |
| All-Time High | $19.80 (Dec 28, 2020) | $59.10 (Aug 08, 2025) |
| % from All-Time High | -90.76% | -1.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.12% |
| Quarterly Earnings Growth | 0.55% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.14% |
| Operating Margin (TTM) | 0.13% | 0.20% |
| Return on Equity (TTM) | 0.23% | 0.37% |
| Debt to Equity (MRQ) | 400.54 | 66.99 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $118.11 | $2.98 |
| Cash per Share (MRQ) | $41.69 | $0.25 |
| Operating Cash Flow (TTM) | $-9,014,839 | $657.12M |
| Levered Free Cash Flow (TTM) | $-7,095,987 | $585.04M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.87% |
| Last 12-Month Dividend | N/A | $0.49 |
Valuation & Enterprise Metrics Analysis: Medirom Healthcare vs Rollins
| Metric | MRM | ROL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.47 | 57.37 |
| Forward P/E | N/A | 51.73 |
| PEG Ratio | N/A | 7.74 |
| Price to Sales (TTM) | 0.00 | 7.86 |
| Price to Book (MRQ) | 0.02 | 19.45 |
| Market Capitalization | ||
| Market Capitalization | $14.22M | $28.08B |
| Enterprise Value | $25.02M | $28.92B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.45 | 8.10 |
| Enterprise to EBITDA | 12.54 | 36.04 |
| Risk & Other Metrics | ||
| Beta | 0.88 | 0.69 |
| Book Value per Share (MRQ) | $118.11 | $2.98 |
Financial Statements Comparison: Medirom Healthcare vs Rollins
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MRM | ROL |
|---|---|---|
| Revenue/Sales | N/A | $822.50M |
| Cost of Goods Sold | N/A | $400.13M |
| Gross Profit | N/A | $422.37M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $142.65M |
| EBITDA | N/A | $172.55M |
| Pre-Tax Income | N/A | $137.54M |
| Income Tax | N/A | $32.30M |
| Net Income (Profit) | N/A | $105.25M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MRM | ROL |
|---|---|---|
| Cash & Equivalents | $2.23M | $201.18M |
| Total Current Assets | $18.33M | $555.97M |
| Total Current Liabilities | $28.32M | $636.82M |
| Long-Term Debt | $13.90M | $783.58M |
| Total Shareholders Equity | $8.05M | $1.36B |
| Retained Earnings | $1.55M | $759.99M |
| Property, Plant & Equipment | $14.04M | $937.26M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MRM | ROL |
|---|---|---|
| Operating Cash Flow | N/A | $162.15M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $140.11M |
| Debt Repayment | N/A | $-408.00M |
| Common Stock Repurchase | N/A | $-14.67M |
Short Interest & Institutional Ownership Analysis
| Metric | MRM | ROL |
|---|---|---|
| Shares Short | 3,836 | 6.67M |
| Short Ratio | 0.17 | 3.99 |
| Short % of Float | 0.00% | 0.02% |
| Average Daily Volume (10 Day) | 13,755,920 | 1,221,540 |
| Average Daily Volume (90 Day) | 4,601,657 | 1,558,340 |
| Shares Outstanding | 53,492 | 484.37M |
| Float Shares | 5.81M | 294.70M |
| % Held by Insiders | 0.26% | 0.42% |
| % Held by Institutions | 0.03% | 0.55% |
Dividend Analysis & Yield Comparison: Medirom Healthcare vs Rollins
| Metric | MRM | ROL |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.49 |
| Last 12-Month Dividend Yield | N/A | 0.87% |
| 3-Year Avg Annual Dividend | N/A | $0.52 |
| 3-Year Avg Dividend Yield | N/A | 0.33% |
| 3-Year Total Dividends | N/A | $1.56 |
| Ex-Dividend Date | N/A | Feb 25, 2025 |